STOCK TITAN
  1. Home
  2. Sec-filings
  3. TNXP
  4. [ARS] Tonix Pharmaceuticals Holding Corp. SEC Filing

[ARS] Tonix Pharmaceuticals Holding Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - Tonix Pharmaceuticals Holding Corp.

ARS Filing - Tonix Pharmaceuticals Holding Corp.

This filing is available as a PDF document.

Filing Type: ARS

Company: Tonix Pharmaceuticals Holding Corp. (TNXP)

Acceptance Date: 20260313

View PDF Document

Source: View Original Filing on SEC EDGAR

Tonix Pharmaceut

NASDAQ:TNXP

View TNXP Stock Overview →

TNXP Rankings

#4637 Ranked by Market Cap
N/A Ranked by Dividends

TNXP Latest News

Mar 12, 2026
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Mar 10, 2026
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia
Mar 9, 2026
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting
Mar 5, 2026
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development
Mar 3, 2026
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting

TNXP Latest SEC Filings

Mar 13, 2026
[8-K] Tonix Pharmaceuticals Holding Corp. Reports Material Event
Mar 12, 2026
[10-K] Tonix Pharmaceuticals Holding Corp. Files Annual Report
Mar 10, 2026
[8-K] Tonix Pharmaceuticals Holding Corp. Reports Material Event
Mar 3, 2026
[8-K] Tonix Pharmaceuticals Holding Corp. Reports Material Event
Feb 26, 2026
[Form 4] Tonix Pharmaceuticals Holding Corp. Insider Trading Activity

TNXP Stock Data

178.78M
12.79M
Biotechnology
Pharmaceutical Preparations
Link
United States
CHATHAM